Mark S. Ordan - Jun 1, 2025 Form 4 Insider Report for Pediatrix Medical Group, Inc. (MD)

Role: Chief Executive Officer, Director
Signature: /s/ Mary Ann E. Moore, Attorney-in-Fact
Stock symbol: MD
Transactions as of: Jun 1, 2025
Transactions value $: $0
Form type: 4
Date filed: 6/3/2025, 05:00 PM
Previous filing: May 12, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
ORDAN MARK S	Chief Executive Officer, Director	1301 CONCORD TERRACE, SUNRISE	/s/ Mary Ann E. Moore, Attorney-in-Fact	2025-06-03	0001208541

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MD	Common Stock	Award	$0	+194K	+147.84%	$0.00	326K	Jun 1, 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2026, twenty-five percent (25%) of the restricted shares will vest on June 1, 2027 and fifty percent (50%) of the restricted shares will vest on June 1, 2028, subject to the terms of the Plan.

Content

Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2026, twenty-five percent (25%) of the restricted shares will vest on June 1, 2027 and fifty percent (50%) of the restricted shares will vest on June 1, 2028, subject to the terms of the Plan.